1. No category

24/7 SERVICE
FOR DIABETES
PATIENTS
p7
DAY 04
ARAB HEALTH
daily dose
THURSDAY
29 JANUARY 2015
T h e o f f i c i a l da i ly n e w s pa p e r o f t h e ara b h e a lt h e x h i b i t i o n
RAK HOSPITAL’S
NEW JOINT VENTURE WITH INDIA’S SHALBY HOSPITALS BRINGS THE
REVOLUTIONARY ZERO ‘0’ TECHNIQUE FOR KNEE REPLACEMENT TO UAE
S
trengthening its positioning as the region’s
new medical tourism destination, RAK
Hospital, the flagship brand of Arabian
Healthcare Group has made a major announcement
at Arab Health by signing an important joint
venture with India’s Shalby Hospitals. As part of the
agreement Dr Vikram Shah, Chairman and Head of
Orthopaedic Department at Shalby Hospitals and
his experienced team members will be regularly
visiting RAK Hospital to conduct procedures in
the area of joint replacement, especially Total Knee
Replacement (TKR) and Total Hip Replacement
(THR). Dr Shah has introduced and innovated the
Zero ‘0’ technique through which he can perform a
joint replacement surgery in 10 minutes, compared
to the conventional two hours to perform the
same surgery. Considered a surgical revolution in
healthcare history, the best part is that the patient
starts walking within three hours of surgery with
the hospital stay shortened to 4-5 days.
Dr Shah’s precision and accuracy in the Total
Knee Replacement surgery, puts him at the top
position in the world. Dr Shah and his team of
surgeons have performed the highest number
of joint replacement surgeries in the world at
a single centre, adding up to more than 50,000
surgeries. Today, on an average, Dr Shah and his
team conducts more than 600 joint replacement
surgeries a month, or 22 operations a day.
Patients in need of Total Knee Replacement
(TKR) and Total Hip Replacement (THR) in UAE,
GCC and African countries will have the most
advanced treatment offered in a convenient
location in UAE at RAK Hospital”, said Dr Raza
Siddiqui, Executive Director of RAK Hospital and
CEO Arabian Healthcare Group.
Speaking on the joint venture Dr Vikram Shah,
Founder, Chairman and Managing Director of
Shalby Hospitals, said, “We are extremely delighted
to offer Shalby’s expertise through RAK Hospital to
UAE and other destinations. “Dubai is well known
for its warm hospitality and rich cultural heritage
and is well connected with all parts of the world
when it comes to travel and logistics. It is really a
great opportunity for us to reach out to patients
in UAE and other destinations and to serve them
with best of our expertise and services”, said Mr
Ravi Bhandari, CEO, Shalby Hospitals.
Dr Raza Siddiqui and Dr Vikram Shah signs the
agreement. Image © RAK Hospital
DUBAI’S CANADIAN SPECIALIST HOSPITAL WINS TOP RATING
FOR MOVE TOWARDS ELECTRONIC MEDICAL RECORDS
Recognition by DHA
underscores CSH’s sustained
efforts to improve patient safety
and minimise medical errors
C
anadian Specialist Hospital (CSH) has
won the topmost rating from Dubai
Health Authority (DHA) for progress
made in electronic documentation in line
with international best practices in integrating
information technology for improved patient care.
The DHA evaluation of the level of electronic
documentation of medical records in hospitals was
based on the internationally accepted Electronic
Medical Record Adoption Model (EMRAM). The
evaluation process also coincides with Dubai’s
‘Smart City’ initiative, aimed to transform the city
into one of the smartest in the world by providing
seamless access to various services and utilities
across high speed wireless internet.
With the paperless system, authorised
persons can update data using the Hospital
Management System so that for doctors, nurses
and caregivers have quick and easy access to realtime patient information. “EMR has its operational
and patient safety benefits. Comprehensive, upto-date and readily available patient information
leads to better diagnosis and treatment as well
as improved monitoring of patients. For hospitals,
accurate and easily accessible data means
significant improvements in operations, particularly
in terms of workflow, productivity and service
quality,” commented Dr Haider Al Zubaidy, CEO,
Canadian Specialist Hospital.
Radius-7
™
EMR also allows sharing of critical patient
information amongst healthcare providers while
safeguarding confidentiality and principles of
medical ethics. The EMRAM model provides
access controls on patient data while patients are
entitled to get a copy of their medical record and
know how it is used and shared.
Dubai hospitals have yet to reach exceptional
levels of EMR adoption as per the EMRAM
standards but the DHA evaluation revealed a
growing level of compliance with international
benchmarks on quality and patient safety.
CSH was recently reaccredited by Joint
Commission International in recognition of the
hospital’s continuing commitment to evidencebased medicine, quality assurance, medical ethics
and patient safety.
PLEASE VISIT MASIMO
Saeed Hall
Stand S1H50
The power of Masimo’s breakthrough
measurements in a patient-worn monitor
With breakthrough rainbow SET® technology and wireless communication,
Radius-7 is designed to allow patient mobility along with continuous
To learn more, visit
www.masimo.co.uk
monitoring, enabling early identification of clinical deterioration.
© 2015 Masimo. All rights reserved.
8631C_Ad_Arab_Health_Daily_Dose_2015_Radius-7_63x267.indd 1
12/23/14 10:04 AM
ARAB HEALTH daily dose
Help for GI Tract Diseases
POEM, ESD among new group’s minimally invasive offerings
T
oday, many GI tract diseases that once
required surgery can now be treated
without incisions. At Cleveland Clinic, a
new Developmental Endoscopy Group can help
your patients with conditions ranging from motility
disorders, such as achalasia, to oesophageal, gastric
and colorectal cancer.
“This new effort combines laparoscopy and
endoscopy, which have traditionally been separate
groups,” explains Matthew D. Kroh, MD, Director of
Surgical Endoscopy in Cleveland Clinic’s Digestive
Disease Institute. “Now we have a core group of
interventional endoscopists who are embarking on
these procedures, functionally operating through
the endoscope.”
The Developmental Endoscopy Group, a fusion
of gastroenterology, general surgery and colorectal
surgery experts, is headed by both Dr Kroh as
Surgical Director and Mansour Parsi, MD, MPH, as
Medical Director.
The main focuses to date are peroral
endoscopic myotomy and endoscopic submucosal
dissection. Here is a closer look at each:
POEM FOR ACHALASIA
Peroral endoscopic myotomy (POEM) is an
entirely endoscopic procedure to treat achalasia.
The technique originated in Japan and has been
performed in the US for approximately two years.
“Through the oesophagus, we make a
small incision in the mucosa and make a tunnel
underneath it”, Dr Kroh explains. “Then, we cut
the muscles in the oesophagus, mainly at the
lower esophageal sphincter, which are too tight in
achalasia. It’s an effective way to release this tension
and restore the ability of food to pass through the
oesophagus and into the stomach.”
The Developmental Endoscopy Group has
successfully completed its first series of POEM
patients. Advantages include requiring no incisions
and patients returning home the following day.
Early data for POEM are compelling, Dr Kroh says.
“It results in dramatic relief of achalasia symptoms,
as good as a surgical (Heller) myotomy, without the
potential morbidity associated with the incisions
on the abdominal wall”, he says.
Cleveland Clinic advanced endoscopist
Madhu Sanaka, MD, underwent POEM training in
Japan under Haroue Inoue, MD, who pioneered
the POEM procedure. Dr Sanaka performs
POEM procedures along with Cleveland Clinic
thoracic surgeon Siva Raja, MD, who specialises
in oesophageal surgeries. Dr Sanaka says,
“Gastroenterologists and surgeons bring different
skill sets to the table, which translates into the best
possible care for the patient.”
ESD FOR GI CANCERS
Endoscopic submucosal dissection (ESD) allows
for the removal of early oesophageal, gastric and
colorectal cancers through an endoscope while
avoiding more invasive surgery. This technique was
developed in Japan where early gastric cancer is
common.
At Cleveland Clinic, gastroenterologist Amit
Bhatt, MD, underwent intensive ESD training in
Japan thanks to grants from the American College
of Gastroenterology and the American Society of
Gastrointestinal Endoscopy.
Dr Bhatt says ESD is valuable in the treatment
of early gastric and esophageal cancer. It allows for a
complete one-piece resection of cancers allowing
pathologists to verify curative resection similar to a
surgically removed tumour, an opportunity that is
New feature brought to you by
26 – 29 January, Plaza Hall
In 1867, Sir Joseph Lister, British surgeon
and pioneer of antiseptic surgery, wrote
a series of reports for internationally
acclaimed medical journal The Lancet, which
dramatically changed the face of surgery to
give us the sterile environments in which we
operate today.
On display in the Future of Surgery Zone
is a rare original 1867 edition of the book
containing these ground-breaking reports
- a donation by USA exhibitors to the Al
Maktoum Medical library during Arab Health.
Visit the Future of Surgery
Zone in the Plaza Hall to
see this incredible historic
artefact for yourself.
Go to the Future of
Surgery Zone for:
· Latest technologies
· Innovation Hub
· Free seminars
2
facebook.com/arabhealth
missed with other endoscopic ablation techniques.
The goal of ESD is to be curative. But, Dr Kroh
adds, if it is not possible to remove the cancer with
negative margins and avoid an operation, ESD
gives the team a better idea of how advanced
the disease is prior to surgical intervention: “For
instance, when a surgeon and a gastroenterologist
do a gastric case together, the beauty of it is that
even if it doesn’t come out endoscopically, the
patient can still get the next less invasive technique.”
Dr Bhatt emphasises that the collaboration
between gastroenterologists and general surgeons
is a remarkable benefit to patients who now have
another option to avoid a traditional intervention.
“Having an advanced endoscopist and a surgeon
work side by side allows us to combine our
expertise, ideas and innovations to develop novel
approaches to problems”, Dr Bhatt explains.
Dr. Sanaka, who also performs ESD procedures
for neoplastic lesions in the GI tract, adds that ESD
is less invasive compared with surgery but has
similar outcomes.
The Developmental Endoscopy Group has
effectively used ESD for both gastric and colorectal
cancers over the past six months.
ESD FOR COLORECTAL
LESIONS
In the US, only a few centres are using ESD to
remove large colonic polyps. At the Digestive
Disease Institute, Emre Gorgun, MD, has been
using the technique for removing such polyps
especially flat colonic lesions, for the past
three years.
Dr Gorgun, who received his ESD training in
Japan, was one of the first US colorectal surgeons
to successfully remove intraluminal lesions en bloc
through the anus using ESD. Overall, he says, ESD is
safe and useful in carefully selected patients.
“ESD is helping us provide better healthcare
and avoid bowel resection”, Dr Gorgun says. He
hopes that ESD will become more widely utilised,
citing data he presented at the last American
Society of Colon and Rectal Surgeons meeting
that only 9% of polyps removed over a five-year
period were actually cancerous.
“So basically 91% of the time, these benign
lesions were overtreated with colectomy”, he
explains. “If you could remove these lesions with
a procedure such as ESD, the patient would be
perfectly treated and the colon would be saved.”
For difficult colonic lesions, Dr. Gorgun also
utilises laparoscopic mobilisation of the colon
performed with combined intraoperative CO2
colonoscopy. Called combined endoscopiclaparoscopic surgery (CELS), this new approach
allows removal of difficult colonic lesions via a
dual technique avoiding formal bowel resection.
CELS is safely offered to selected patients with
benign polyps or early colonic neoplasms that
could not purely be removed via colonoscopy.
This combined approach is successfully
performed at Cleveland Clinic by Dr Gorgun
with good outcomes.
Cleveland Clinic is a sponsor of Arab Health
2015. Specialists from Cleveland Clinic’s Digestive
Diseases Institute, including, Matthew D Kroh,
MD, will be presenting at the 7th Middle East
Gastroenterology Conference.
To s
pea
MEDIA
k th
e
dur
Hea
ing team
thelth, vi Arab
s
loc press it us
i
a
C, a ted inofficen
bov
A
e Ha l Ain
ll 3
Today at a glance
Arab Health 2015 Congress
Conference
ROOM
Location
Start Time
Finish
Leaders In Healthcare
Al Multaqua Ballroom
Between Halls 4 and 5
10.00
14.00
Clinical Chemistry (Medlab)
Sk Maktoum Hall - Part B\C Shk Maktoum Hall
09.30
16.00
Haematology (Medlab)
Shk Rashid Hall - Part C
Shk Rashid Hall
10.00
16.30
Total Radiology
Shk Rashid Hall - Part D
Shk Rashid Hall
09.00
15.30
RCSD
Ajman D\ Fujairah A
Above Hall 7
09.50
16.30
Anaesthesia
Abu Dhabi A
1st floor opposite Hall 5
09.00
16.30
Gastroenterology
Abu Dhabi B
1st floor opposite Hall 5
08.50
17.50
Cardiovascular Disease & Intervention
Ras Al Khaimah
2nd floor opposite Hall 5
08.50
16.30
Surgery
Umm Al Qwain
2nd floor opposite Hall 5
09.00
16.00
Big Data
Al Ain J&K
Above Hall 4
09.50
17.00
THURSDAY 29 January 2015
Arab Health Daily Dose
The Arab Health Daily Dose is the official newspaper of the
Arab Health Exhibition & Congress. Distributed Monday 26
January-Thursday 29 January 2015.
DIRECTOR - PUBLICATIONS
Joseph Chackola [email protected]
EDITOR
Elin Boyd [email protected]
SALES MANAGER - PRINT & ONLINE
Waseem Ashraf [email protected]
SENIOR GRAPHIC DESIGNER
Mark Walls [email protected]
PRINTED BY
Zabeel Printing Press www.zppdubai.ae
The Arab Health Daily Dose is owned and distributed by Informa Exhibition
Life Sciences, Floor 19, World Trade Centre Tower, Dubai, UAE.
All images © Shutterstock.com unless otherwise specified.
This publication may not be reproduced or transmitted in any form in whole
or part without the written consent of the owners.
For more information on Informa Exhibitions Life Sciences publications, please
visit www.arabhealthmagazine.com
Download the free Arab Health
mobile app
DOWNLOAD NOW
arabhealthonline.com/mobileapp
FUTURE OF SURGERY
Arab Health 2015 is featuring the newly launched Future of Surgery
Zone, which consists of a designated area where top specialists in the
healthcare sector are running hands-on training sessions on the most
sophisticated and up-to-date devices and technology.
Attend absolutely free!
The article ’Smart healthcare: The key to improving care in an
ageing world’ published on page 7 in the Daily Dose yesterday did
not picture Mickael Ghossein, Senior VP Middle East, North Africa
and Turkey, Orange Business Services. Below is the correct image.
Visit the Future of Surgery Zone in Plaza
Hall every day during Arab Health
HIGHLIGHTS
 Innovation hub seminars (see schedule below)
 Interactive touchscreen displays to plan your Future of Surgery experience
 A rare 1867 edition of medical journal, The Lancet
 A glance at the history of surgery
 Meet one on one with experts in the field
 See the 3D printed baby heart that allowed doctors from New York- Presbyterian Morgan Stanley’s
Children’s Hospital better plan ahead of surgery on a very complex and unique heart malformation
DAY 4 programme
TIME COMPANY TOPIC
11.00
DePuy Joints
Stability in motion
11.30
NYP
3D printing of the heart: Model for surgery planning
12.00
Primal Pictures
3D human anatomy in real-time
12.30
Ethicon Sutures
Latest innovation in wound closure - STRATAFIX
13.00
NYP
Minimally invasive neurosurgery
13.30
NYP
Robotic prostatectomy
14.00
NYP
Transanal endoscopic microsurgery
15.00
Primal Pictures
Orthopaedic surgery: a 3D resource for a 3D subject
15.30
NYP
Faecal incontinence and sacral nerve stimulation
16.00
Ethicon Biosurgery
Advances in Surgical Haemostasis - pipe line presentation
16.30
NYP
Combined Endo-Laparoscopic Surgery (CELS)
17.00
Ethicon Bariatric
Science of tissue management - Bariatric procedures
17.30
NYP
Strategies of the recurrence of Crohn’s Disease
#arabhealth
@arab_health
3
ARAB HEALTH daily dose
UK PRESSURE SPECIALIST SET TO UNVEIL
SECOND MATTRESS AT ARAB HEALTH
A
s well as launching the pioneering Airflex®
Trio, the pressure ulcer specialist will
also be presenting AirCaire® Duo to
the exhibtion, an advanced two cell cycle overlay
mattress that combines state-of-the-art pressure
control technology.
The innovative mattress provides enhanced
comfort and complete pressure elimination at
regular intervals. It has integrated sides to aid
patient safety and has variable pressure options to
cater for patients of all sizes up to 180kg. It also has
a built-in Cardio Pulmonary Resuscitation (CPR)
valve, which provides quick deflation in the case
of an emergency.
The easy-to-use, cost-effective AirCaire®
Duo mattress system has been designed to offer
maximum flexibility to patients who are at risk
of pressure damage. It is an effective and proven
solution in the prevention and treatment of
pressure ulcers and is ideal for hospital and home
care environments.
AirCaire® Duo has been designed in conjunction
with a range of healthcare professionals who
understand the importance and the pressure
relieving qualities of a dynamic airflow mattress.
Rober are leaders in the development and
manufacture of pressure ulcer prevention and
therapy product ranges and this new pioneering
technology compliments their existing portfolio of
products. The Airflex® Trio and the AirCaire® Duo
are the first of a new generation of mattresses to be
launched, which through innovated design fulfils the
requirement in the market for affordable healthcare.
Mike Hutson, Chief Executive of Rober, said:
“We have had such a positive reaction since we
announced we would unveil the Airflex® Trio
mattress at Arab Health that we decided to also
launch the AirCaire® Duo in the region as well”.
“Pressure ulcers dramatically increase the cost
of each patient’s care bill and are also linked to
prolonged hospitalisation, pain, social isolation
and in worst cases, death. Our mattresses are the
perfect solution to this and have the potential to
prevent thousands of patients across the Middle
East from getting pressure ulcers as they are cared
for in hospital”.
Rober will be located at stand Z1C18 in the
Za’abeel Hall.
Image © Rober
ROCHE DIAGNOSTICS REVEALS ITS LATEST
AUTOMATED WORKFLOW SERIES IN THE MIDDLE
EAST FOR THE FIRST TIME AT ARAB HEALTH 2015
3D intelligent bi-directional lab automation system for fast and precise diagnosis
T
he prognosis of each patient depends
on a number of factors, but one thing
is certain, a fast, precise and reliable
diagnosis is essential to achieve the best
outcome. With the right systems running in a
laboratory, healthcare professionals can deliver
smooth and efficient in vitro diagnostic services.
At the 40th Arab Health Exhibition, Roche
Diagnostics revealed the cobas® 8100, one of
its latest laboratory automation solutions that
will support the various and changing needs
of central laboratories. Displayed for the first
time in the Middle East, the 3D intelligent
cobas® 8100 solution is designed to provide
healthcare professionals with real medical value
in comprehensive technology.
level for full carriers and a lower level for empty
carriers. Even during a laboratory’s peak times,
this system ensures that empty carriers are
not obstructing sample transportation, allowing
faster access to each processing step and shorter
turnaround time. Unlike previous analysers, the
smart routing of samples with the cobas® 8100,
ensures that they only go to necessary modules,
further reducing turnaround times.
Designed to allow minimal manual sample
handling, the cobas® 8100 ensures sample
integrity and volume check by conducting
broad sample volume and quality assessment
early in the pre-analytical process. In addition,
the solution’s integrated post-analytic options,
enables fast, automated access to samples, for
any post-analytical requirement, at any time.
Combined with Roche’s IT connectivity solution,
the cobas® 8100 offers real-time tracking from
sample entry to archiving so that the location of
a sample is known at any point in the process.
Taking advantage of the highly consolidated
and connected cobas® pre-analytical, analytical
and post-analytical solutions, the cobas® 8100
has a wide-range of connectivity options that
make it easily adaptable to any laboratory’s
needs. It can be connected to Roche’s highly
consolidated analysers for clinical chemistry
and immunoassay testing, coagulation, urinalysis
and haematology.
Displayed at the Roche Diagnostics Middle
East stand during Arab Health, the cobas® 8100
builds on long-standing experience, the highest
quality standards, and the unmatched reliability
of Roche’s solutions. Serving all laboratory
automation needs, its high sample throughput
with a single point-of-entry is advanced in the
world of automation. Its workflow intelligence
and flexibility will maximize the ability of
laboratories to achieve fast, accurate and
reliable results.
For a first-hand look at the advanced
technology and much more, visit the Roche
Diagnostics Middle East at Sheikh Maktoum Hall,
stand MC10.
WORKFLOW WITH
INTELLIGENCE
Whether a laboratory has high-throughput,
short turnaround time or both, the cobas® 8100
can fulfil a laboratory’s needs, allowing faster
and more efficient workflow. With the system’s
3D intelligent bi-directional transportation,
the automated workflow series can deliver
high-throughput sample processing, critical for
physicians and patients as they wait for results.
The transport lines lie on two levels, an upper
Image © Roche Diagnostics
Visit the UK Pavilions
for the best in Medical Technologies
Zabeel Hall UK Medical Technologies Pavilion | Sheikh Rashid Hall UK Laboratory Technologies Pavilion
Don’t miss the UK Pavilion Surgical Simulation Demonstrations
Visit the ABHI Stand Z1D30
4
3828 ABHI Strip Ad 63x267.indd 1
facebook.com/arabhealth
19/01/2015 12:33
THURSDAY 29 January 2015
MASIMO RADIUS-7™ – FIRST RAINBOW® SET® NONINVASIVE WEARABLE, WIRELESS MONITOR FOR ROOT®
Continuous, untethered monitoring of oxygenation, circulation,
respiration, and anaemia designed to mobilise patients
R
adius-7™ for the Root® patient
monitoring and connectivity platform
is the first and only wearable, wireless
monitor with Masimo’s breakthrough rainbow®
SET® technology, enabling early identification
of clinical deterioration while offering patients
continuous monitoring with freedom of
movement.
With rainbow® SET® non-invasive
measurements, Radius-7™ with Root® can
aler t clinicians at the bedside or remotely.
The Masimo Patient SafetyNet™ remote
monitoring and notification system warn
of critical changes in a patient’s oxygen
saturation and pulse rate, even during states
of motion and low perfusion, as well as
respiration through acoustic respiration rate
(RRa®), or haemoglobin that may indicate
pulmonary, cardiac, or internal bleeding
problems.
Lightweight at only 155 grams, the
Radius-7™ attaches to the patient’s arm or
can be placed alongside the patient in their
bed, allowing untethered monitoring while
they are in bed or out. With no need to
disconnect and reconnect the cable to get
out of bed, the Radius-7™ reduces the need
for nursing assistance. And the Radius-7™’s
wireless communication functionality, either
shor t-range via Bluetooth back to Root®
or with upgradeable Wi-Fi for long-range
communication, ensures the patient can be
continuously monitored and connected to
caregivers wherever they are in the hospital.
Studies have shown that patient mobility
is a key factor in more rapid patient recovery.
Radius-7™ allows clinicians to mobilise their
patients.
“With this new technology we have made
another important step to improve patient
safety”, said Caroline Stade, Chief Nursing
Officer at University Children’s Hospital Basel
(UKBB) in Basel, Switzerland. “Children can be
cared for and move about as they are able, while
remaining under seamless, clinical surveillance.
This makes parents, and of course, nurses and
clinicians, feel better about the quality of care
offered to our paediatric patients”.
“In the past, wearable patient monitoring
offered only limited measurements that were
often plagued by false alarms. Radius-7™
allows untethered clinically relevant patient
monitoring”, said Masimo founder and
CEO Joe Kiani. “We expect Radius-7™ and
Root® to change how hospitals think about
monitoring, ushering in a new level of
patient safety”.
REFERENCES
References available on request (magazine@
informa.com)
Images © Masimo
PTS DIAGNOSTICS WILL UNVEIL NEW
CAPILLARY TUBE AT ARAB HEALTH
Lipid, Glucose and A1C testing systems innovate Point of Care Testing
P
TS Diagnostics, the US-based manufacturer
of both the CardioChek® brand and
the A1CNow® family of Point Of Care
diagnostic products, announced that it is
launching new capillary tube technology at Arab
Health. In addition, PTS Diagnostics is offering
demonstrations of its CardioChek analyzers and
A1CNow+ systems by providing free cholesterol
(lipid) and HbA1c results during Arab Health from
its stand in the US Pavilion, Za’abeel Hall 4 at stand
Z4E18.
The PTS Diagnostics Capillary Tubes provide
better efficiency and are designed to be easier to
use than traditional blood transfer tubes. Using
a single glass tube with plastic casing, the PTS
Diagnostics Capillary Tubes provide consistent
self-wicking technology to preset volumes. This
improved design is perfect for all blood collection
needs including a wide range of applications across
many different medical devices. In addition, the new
PTS Diagnostics Capillary Tubes provide significant
savings over traditional transfer tube technology
with the same or better quality.
 These new PTS Diagnostics Capillary Tubes can
increase efficiency in workflow by providing:
 Ease-of-use with no assembly
 One-hand blood collection and dosing
 A glass tube to ensure easy blood collection
 Bulb-squeeze dispensing technology that ensures
consistent performance
 Only one item to inventory (no plunger)
.
PTS Diagnostics’ handheld, highly accurate, fast,
and economical diagnostic devices empower the
medical community to quickly measure HbA1c and
glucose, and generate a lipid (cholesterol) profile,
all at the Point Of Care. PTS Diagnostics’ portfolio
includes the following systems:
CardioChek professional analysers address
the connection between heart attack, stroke, and
diabetes by providing on-site lipid panel (total
cholesterol, HDL cholesterol, and triglycerides)
screening results in as little as 90 seconds and can
also measure glucose. CardioChek professional
analyzers calculate LDL cholesterol, the TC/HDL
ratio, the LDL/HDL ratio, and non-HDL cholesterol
The A1CNow+ system provides healthcare
professionals with a fast, easy and accurate method
of obtaining HbA1c results while the patient is in
the exam room. In just five minutes, clinicians have
information to provide an immediate consultation
with a patient. The A1CNow+ system is critical to
diabetes management and is fully reimbursable.
THE NEW AND
Novotel Hotel
7
g
3
Rashid
2
5
2
Sheikh
rkin
6
rse
Pavillion
Za’abeel 3
Pa
Za’abeel 2
Maktoum
id
Pa
Za’abeel 1
1
Go to Za’abeel Hall 4
Stand Z4N60
Sheikh
8
cou
Con
EXCLUSIVE
Za’abeel 4
Ibis Hotel
4
Al Multaqua Registration
Ballroom
Concourse 1
Trade Centre
Arena Plaza
(Outside Area)
Arena
#arabhealth
Sheikh
Saeed 1
Sheikh
Sheikh
Saeed 2 Saeed 3
@arab_health
Plaza
Hall
5
ARAB HEALTH daily dose
DUBAI HEALTHCARE CITY ADVANCES
MEDICAL EDUCATION IN THE UAE
By: Shiran Illanperuma, Informa Life Sciences, Dubai, UAE
A
dvancements in Dubai Healthcare City’s
operations in the field of research and
education were particularly notable in a
region with much room for growth in these areas.The
recently announced Mohammed Bin Rashid University
of Medicine and Health Sciences (MBR-UMHS),
which will be homed in the Mohammed Bin Rashid
Academic Medical Centre, along with the pre-existing
Khalaf Ahmad Al Habtoor Medical Simulation Centre
and the Al Maktoum Medical Library, seeks to fill the
void in healthcare education in the UAE.
Marwan Abedin, Chief Executive Officer of
DHCC announced that the city had “marked 12
years of growth and introduced advanced standards
of governance for licensing and complaints, and
signed agreements with strategic partners to
advance healthcare and medical education” in 2014.
The College of Dental Medicine is already
operational as part of the MBR-UMHS and offers
six postgraduate programmes, accredited by
the Ministry of Higher Education and Scientific
Research, in collaboration with the UK-based Royal
College of Surgeons of Edinburgh. Thus far the
most popular specialities in these programmes have
been orthodontic- and paediatric dentistry and oral
surgery. The college emphasises a diverse body of
residents and professors, hailing from the UAE and
neighbouring Middle Eastern regions such as Saudi
Arabia, Jordan, Palestine, Syria and Iran, as well as
further off countries like Greece, the UK and India.
The medical simulation centre, which is the first
state-of-the-art comprehensive training facility in the
region, had an eventful year. Conducting close to 150
training sessions, it reached 2,120 multidisciplinary
healthcare professionals and students from the
UAE and across the globe. The courses conducted
feature training in several technical and soft skills
covering a variety of areas in medicine and clinical
trauma. This diversity in training was furthered
by the donation of an ambulance simulator from
Mediclinic Middle East, enabling an expansion of its
emergency response programmes.
The medical library meanwhile, endeavours to play
a pivotal role in support of education, research and
clinical care at Dubai Healthcare City. During 2014,
the number of registrants stood at 1,431. Additionally,
4,600 individuals visited the library’s resources to
access 16 electronic databases and e-resources,
16,500 eBooks and journal titles cumulating to a
staggering total of 357,818 database hits.
The Al Maktoum Medical Library also sought
to promote education in healthcare through the
conduction of workshops for registered members.
Workshops addressed topics such as, ‘How to
publish your research in international scientific
journals’ in collaboration with Springer and Edanz,
‘database training’ in collaboration with OVIDEBSCO, Springer and ClinicalKey; and an orientation
and training session for the Dubai College of Dental
Medicine, Royal College of Surgeons in Ireland and
European University College residents.
Dubai Healthcare City had a productive 2014,
pursuing its aims to establish an integrated academic
and clinical environment to advance medical education
in the Middle East region. Thanks to the simulation
centre and medical library and their numerous
workshops, simulations and training sessions, as well
as the upcoming medical university, Dubai Healthcare
City seems well placed to meet the growing needs of
healthcare education in this region and beyond.
Your CT world,
now in living color
A first-of-its-kind innovation, Philips IQon Spectral
CT* uses on-demand color quantification to help you
identify the composition of what you see. You get
anatomical information and the ability to uncover
structures based on material content.
Visit us at Arab Health booth # S2C10
* The IQon Spectral CT is not yet CE Marked. Not available for sale in all regions.
Discover the difference for you at
www.philips.com/IQonSpectralCT
6
facebook.com/arabhealth
Image © Informa Life Sciences Exhibitions
THURSDAY 29 January 2015
24/7 SERVICE FOR YOUNG DIABETES PATIENTS
Paediatrician Henk-Jan Aanstoot has implemented an innovative
concept for treating diabetes in children and adolescents
A
s often as five times a day, Isabelle has to
measure her blood-sugar levels. She stores
all of the information in her digital patient file.
“It’s so easy!” exclaims the 11-year old girl. To transfer
the data, she simply has to connect the glucose sensor
to her laptop via the USB port, and a graphic with
numerous colourful rectangles automatically appears
on the screen, most of them green. “Luckily”, says
Isabelle, “because that is good”. The (fasting) glucose
level is usually around 100mg/dl. Blue rectangles
indicate the blood sugar is too low; red is too high.
COMPREHENSIVE ONLINE
CARE APPROACH FOR
DIABETES
Isabelle has learned to interpret the readings
herself. A red rectangle is not necessarily a reason
to worry, but if two consecutive readings show
that the level is too high, she has to send an email
to Diabeter, the Netherland’s National Centre for
Diabetes in children and adolescents, in Rotterdam,
where she is in treatment.
SERVICE AROUND THE CLOCK
Diabeter patients are treated 24 hours a day.
Someone is always available, even in the middle of
the night, thanks to the one-of-a-kind 24/7 service.
“Thanks to eHealth, the contact can be very
intensive, and the patients don’t have to travel to
our offices in Rotterdam”, explains Dr Henk-Jan
Aanstoot, one of the co-founders of Diabeter. “It’s
not just practical, it’s also cost-effective”.
YOUNGER AND YOUNGER
PATIENTS
The vast majority of diabetes patients have type
2 diabetes. Today, more and more people
are developing type 2 diabetes. “That wasn’t
always the case.” According to Aanstoot, the
number of patients with type 1 diabetes is
also growing. Type 1 diabetes does not involve
insulin resistance. It is an autoimmune disease,
which means that the body’s own defence
system attacks the insulin-producing cells in the
pancreas. Children have always developed type
1 diabetes, but they are getting younger and
younger. The number of children under the age
of five who have developed type 1 diabetes has
doubled in the last five years and grows by 5%
each year. Diabeter’s patients range from bir th
to 25 years of age, and almost all of them have
type 1 diabetes.
DECREASING HBA1C
LEVELS
Patients visit the treatment centre at least
four times a year to have their HbA1c level
measured. This reading allows conclusions
to be drawn about the blood-sugar readings
from the previous three months and should
be below 52mmol/mol to reduce the risks of
long-term damage, which can include stroke,
hear t attack, blindness, kidney failure or the
amputation of limbs, explains Aanstoot. Thanks
to the comprehensive diabetes care approach,
Diabeter patients’ HbA1c levels decrease on
average from 69 to 58mmol/mol within a year.
SAVING TIME AND MONEY
The measurements are taken using Siemens
DCA Vantage® analysers. In just six minutes,
these machines analyse the blood and print out
Siemens DCA Vantage® analyser patients can have their blood analysed in just six minutes
patients have to be admitted to hospital for
possible complications. According to Aanstoot,
for diabetes patients who are treated by a
paediatrician in a hospital, the number is 20-50%,
in other words, almost ten times more.
test results and patients immediately know where
they stand. Another major advantage is that
doctors need only a small drop of blood from the
patient’s fingertip for the HbA1c measurement.
Since lab techs are not needed to analyse the
blood, the HbA1c analyses are not only faster, but
also cheaper than if done in an external lab.
DE-ESCALATION
This is down to the comprehensive care
approach, which ensures that the situation
does not escalate, for example, when a child
has diarrhoea or a fever. All in all, this means
insurance companies only have to pay €3,000
a year for a Diabeter patient, €1,000 less than
for other diabetes patients, estimates Aanstoot.
THE MOST EXPENSIVE
HOTELS IN THE WORLD
The third and largest cost-saving factor is the
length of hospital stays at Diabeter. “Hospitals
are the most expensive hotels in the world”,
says Aanstoot. Each year, only 3% of all Diabeter
Test smarter. Run faster.
Siemens answers unite clinical and workflow excellence to help you thrive.
www.siemens.com/arabhealth
Clinical diagnostic testing is part science and part business. Which
means its overall performance depends on how well these two
integral parts work together. Siemens Healthcare Diagnostics can
make that happen. We offer answers that combine the extensive
menu of tests you want with the leading-edge technology you
need to run them efficiently. Not only do we deliver assays to
support your clinical excellence, we commit all our technical
know-how to developing innovative diagnostic solutions that
increase productivity. What’s more, we provide the education,
services, and support that keep you running at your absolute
best. So you can unite and transform both clinical and workflow
performance to deliver the highest-quality patient care.
Find out how Siemens helps you work better by working with you.
Visit siemens.com/test-smarter.
Visit us at
Sheikh Rashid
Hall
Stand No. RC10
Answers for life.
#arabhealth
@arab_health
7
ARAB HEALTH daily dose
GE SUPPORTS BETTER HEALTHCARE FOR UAE
H
ealthcare enhancement is a strategic
pillar of the UAE’s development strategy
underlined by the priority that the nation
places on health in its 2015 federal budget.
Announcing the draft budget, His Highness
Sheikh Mohammed bin Rashid Al Maktoum, UAE
Vice President and Prime Minister and Ruler of
Dubai, had observed: “Investing in UAE citizens
and meeting their needs is the cornerstone of
government policies, and is at the forefront of
priorities of the National Agenda, which aims to
achieve UAE Vision 2021”.
GE Healthcare is supporting the nation in driving
its healthcare infrastructure through its public and
private partnerships, which span not only the
provision of advanced technologies but also turnkey
hospital infrastructure development support.
Maher Abouzeid, President and CEO of GE
Healthcare for Turkey and the Middle East, said:
“With a strong presence in the UAE for nearly
four decades, we understand the objectives of
the government and the people in enhancing
the country’s healthcare infrastructure to truly
world-class standards. We have more than 6,500
products and technologies deployed in hospitals
and clinics across the UAE”.
The Sulamain Habib Medical Group (SHMG)
will open a brand new facility in Dubai this year,
fully equipped with GE’s technology. GE Healthcare
is already partnering with SHMG on more than
ten projects in the region including in Saudi Arabia,
Bahrain and Dubai. This new facility will feature
some of GE’s advanced technologies being installed
for the first time in the region. This includes GE’s
Revolution CT, a state-of-the-art technology
that uses high-resolution and motion correcting
technology similar to the image stabilisation features
in personal cameras. The technology, which allows
capturing a motion-free image of the human heart
in just one beat, will help address the increasing
incidence of cardiovascular disease in UAE, one of
Image © GE Healthcare
the leading causes of death in the country.
GE is also providing its latest CT technology
to the radiology departments of 11 out of 15
Ministry of Health hospitals in the country. These
installations are in line with the MoH’s strategic
Are you a dealer
or distributor?
Enjoy access to
your exclusive
plan to modernise and innovate hospitals across
the nation with advanced technology and facilities
for UAE citizens. “We are proud to see our latest
generation of CT being installed in the UAE for
the first time on a global scale. This highlights the
MoH commitment to provide high standards of
healthcare to UAE citizens”, added Abouzeid.
Elsewhere in the UAE, GE Healthcare is
enhancing the quality of infant care, providing
more than half of the medical technology
available at Al Jalila Children’s Specialty Hospital in
Dubai. The first specialised children’s hospital in
the UAE, the 200-bed facility was a gift to UAE’s
children by His Highness Sheikh Mohammed Bin
Rashid Al Maktoum, to celebrate his daughter Al
Jalila’s first birthday.
GE’s equipment there includes the world’s first
high definition CT scanner, the Discovery 750 HD,
the Giraffe OmniBed, an incubator with an builtin warmer designed to provide uniform heat to a
premature baby, and the VScan, a handheld device
based on ultrasound technology, which can be
used to easily assess internal fluid flow, and which
is about the size of a smartphone so that clinicians
can carry it in their pockets.
Al Jalila’s cardiac, radiology and emergency
departments will be equipped with GE’s ultrasound
solutions, and, for the first time in the UAE, all
technologies will be connected to the Dubai
Health Authority network via an IT system called
EchoPAC and an imaging storage system called
ImageVault. This will allow Jalila Hospital clinicians
to communicate and collaborate more effectively,
by sharing images and reporting on cases between
two of the main hospitals in Dubai, Rashid and
Dubai Hospital. This is expected to lead to more
confident diagnoses and treatment decisions.
GE Healthcare’s advanced technologies used in
hospitals in the UAE are exhibited at Arab Health,
with a stand larger than 525m2 in area, designed to
mirror the hospital environment.
Also this year, GE Healthcare is introducing
the ‘GE Arab Health’ mobile app to help visitors
navigate their way through the new technologies
GE is presenting. As Platinum Sponsor of the event,
GE Healthcare is also extending its support to the
conferences on Big Data, Leaders in Healthcare,
Biomedical Engineering and Radiology.
NATURAL WELLBEING LTD (UK) SIGNS
MAJOR DISTRIBUTOR FROM LEBANON
Za’abeel 4
Ibis Hotel
4
Al Multaqua Registration
Ballroom
Concourse 1
Trade Centre
Arena Plaza
(Outside Area)
Arena
Sheikh
Saeed 1
Sheikh
Sheikh
Saeed 2 Saeed 3
Go to Za’abeel Hall 4
Stand Z4N60
8
facebook.com/arabhealth
Plaza
Hall
g
Rashid
rkin
Pa
3
Sheikh
2
5
2
rse
1
6
id
Pa
7
Pavillion
Za’abeel 3
cou
Za’abeel 2
Maktoum
Con
Za’abeel 1
N
Novotel Hotel
Sheikh
8
atural Wellbeing Ltd (UK) part of
NutraHealth Plc is already hailing
its visit to Arab Health 2015 a
success after signing a substantial deal with a
major distributor from Lebanon.
The company came to exhibit at Arab
Health to focus on targeting the Middle East
markets, with a specific focus to target new
business opportunities with the Lebanese
market. Darren Lister, Business Development
Director at Natural Wellbeing said: “We are
delighted that as a result of the Arab Health
show, on day one we have secured a significant
contract with Lebanon. “This new agreement, which sees a range
of our 11 new VitPlus+ products going into
Lebanon, is a substantial piece of business
for Natural Wellbeing and will progress very
quickly.
“Without the support of Medilink and
also UKTI, the show would not have been as
successful for us.”
Natural Wellbeing sells to 70 countries
across six continents and are currently
registering a further 26 additional
international markets. The company recently
won the Medilink West Midlands Medical
and Healthcare Business Award for Export
Achievement.
The company is currently showcasing
its innovative vitamins, supplements and
minerals portfolio including their brand new
Vitagenics® and Monkey Wellbeing product
ranges on stand Z1C14 in the Za’abeel Hall.
THURSDAY 29 January 2015
#arabhealth
@arab_health
9
ARAB HEALTH daily dose
/ArabHealthExhibition
NEWYORK-PRESBYTERIAN HOSPITAL
PARTICIPATING AT ARAB HEALTH
FUTURE OF SURGERY ZONE
Subscribe to our
YouTube Channel
to keep up to date
with all our videos
and products
W
e are thrilled to have our Global
Ser vices team par ticipate with
the Future of Surger y at the Arab
Health. We are embarking on an exciting
time at NYP as we continuously expand
our international outreach”, said Mr Michael
Merritt, Vice President of Global Ser vices for
NewYork-Presbyterian. “NYP is committed to
its integrative mission of patient care, teaching,
research, and community ser vice and how that
can help other organisations abroad improve
care locally”, he continued.
NYP Global Services offers free seminars at
the Innovation Hub as a part of the event’s Future
of Surgery Zone on topics such as strategies of the
recurrence of Crohn’s disease, combined Endo-
laparoscopic surgery (CELS), transanal endoscopic
microsurgery, robotic prostatectomy, and minimally
invasive neurosurgery. NYP also showcased a 3D
printed heart model, discussing the impact this
innovation will have in advancing surgical care,
and more importantly, proving the lives of patients
suffering from congenital heart disease.
The physicians and surgeons of NYP’s
Weill Cornell Medical College and Columbia
University College of Physicians and Medicine
frequently lead the development and
application of advanced medical, inter ventional,
and surgical technologies. From diagnosing rare
and complex disease for adults and children
to performing lifesaving inter ventions, NYP’s
Weill Cornell Medical College and Columbia
University College of Physicians and Surgeons
are amongst the most sought after in the
world. Ranked by US News as a top hospital
for more than ten consecutive years, NYP has
many centres of excellence that provide highly
specialised ser vices, including, but not limited
to children’s, cardiac, neurologic, digestive,
oncology, transplant, and burn trauma.
NYP Global Ser vices has recently
established a permanent presence in the
region by opening an office in Riyadh, Kingdom
of Saudi Arabia. The office facilitates access
to the exper tise of NewYork-Presbyterian
and its two primar y medical school affiliates,
Columbia University College of Physicians &
Surgeons and Weill Cornell Medical College.
VIAMED TO LAUNCH NEW CAPNOGRAPH MONITOR
TECHNOLOGY TO MIDDLE EAST AT ARAB HEALTH
U
K-based Viamed is exhibiting its
range of recently launched innovative
medical devices at Arab Health
2015, including the company’s high tech
VersaStream® Capnography sampling lines and
SMARTSat® SpO2 OEM boards.
VersaStream provides an innovative solution
for Sidestream Gas Monitoring for use with
most Capnographs and Multigas Monitors. The
VersaStream® gas sampling lines are a costeffective alternative to Nafion® tubes. The gasselective non-porous material facilitates fast and
complete removal of condensation from the
sampling line and the integrated bacterial filter
prevents contamination, as well as speeding up
patient monitoring preparation time.
Viamed will also be demonstrating its
other portable Capnograph monitors. The
Capnograph monitors will warm-up and be
ready to use at full accuracy within ten seconds,
providing a huge advantage for clinicians
working in the emergency and critical care
environments.
Viamed will also showcase the SMARTsat
technology platform from its pulse oximetry
range, which has been developed in close
co-operation with well-established research
institutions and university hospitals. SMARTsat
technology has extremely low power
consumption requirements, and is a real
alternative for OEM customers whom require
high-end pulse oximetry solutions for their
applications.
Viamed focuses on the development,
production and distribution of innovative
medical products worldwide. The main
application for products is critical patient care
in hospitals, other marketed areas include
emergency services, General Practitioners,
dental and veterinary surgeries.
Ryan Swaine, International Sales Manager
of Viamed Ltd, said: “We’re looking forward to
exhibiting our products to the Middle East market,
particularly the recently launched VersaStream
and SMARTSat OEM boards. We are keen to
enhance our relationship with distributors and
clinicians in the Middle East region. Arab Health
is the perfect opportunity for us to begin raising
awareness of our innovative product portfolio”.
Viamed will exhibit a selection of its product
ranges at stand Z1H70 in Za’abeel Hall.
Image © Viamed
ZEBRA TECHNOLOGIES HIGHLIGHTS THE PATIENT SAFETY AND
HOSPITAL BENEFITS OF CONVERGING MOBILITY, CLOUD AND
INTERNET OF THINGS FOR THE MIDDLE EAST HEALTHCARE SECTOR A
n Institute of Medicines landmark report
stated that preventable medical errors
cause up to 98,000 deaths and 770,000
adverse events in the US each year. In 2004/5
alone, the UK’s NHS (National Health Service)
faced more than £400 million worth of clinical
negligence claims; one of the key-causes being
patient misidentification. The National Patient
Safety Agency states that this causes 19% of all
hospital errors. The UK Government estimates
that errors associated with mistaken identity
cost the NHS approximately £2 billion in extra
bed days. Medication errors alone account for an
estimated 5% of annual medical malpractice claims
in the US.
Proven practices such as barcode based safety
initiatives are underpinning hospitals’ efforts to
meet the patient safety requirements set by
industry accrediting bodies. The Joint Commission
10
facebook.com/arabhealth
International (JCI), which sets the standards for
many of the region’s major hospitals, has its own
International Patient Safety Goals designed to
reliably identify the patient and match the treatment
to the patient; it is a serious issue as, according to
the JCI, ‘wrong-patient errors occur in virtually all
aspects of diagnosis and treatment’.
Patient wristbands can help identify patients
but many studies have shown that between 2-6%
of patients aren’t properly identified by their
wristbands. Identification technologies such as
barcoded wristbands and RFID radio frequency
technology provide the patient with a ‘virtual
voice’ and can link to systems such as electronic
health records for fast access to accurate patient
information.
Zebra Technologies, following its acquisition of
Motorola Solutions’ Enterprise Business in 2014, is
converging mobility, Cloud, RFID and the Internet
of Things (IOT) to enhance efficiency, productivity
and patient safety in the region’s hospitals. At Arab
Health 2015, Zebra are presenting the latest patient
ID integrated printing solutions for the region’s
healthcare sector, including a range of mobile printers
for the healthcare sector and Laserband barcoded
wristband technology for barcode scanning at the
point of care, to help hospitals deliver accurate
patient ID and sample/blood/medication labelling at
the patient’s bedside.
The Zebra range of desktop and mobile
healthcare printing solutions are already in use in
the GCC across a range of hospital operations
from patient admission desk to the bedside, as well
as the medical laboratory and hospital pharmacy.
Hospitals can print critical information such as
dosage information and prescription labels, bedside
sample collection, patient ID wristbands and staff ID
cards using Zebra’s solutions. THURSDAY 29 January 2015
CLEVELAND CLINIC ANNOUNCES ‘YOUNG CLINICIAN OF THE YEAR’
AT 2015 ARAB HEALTH ACHIEVEMENT & INNOVATION AWARDS
Young physician receives accolades for impacting patient lives in the Middle East
I
n keeping with its continuous support of the
Middle East medical community, Cleveland
Clinic presented the fourth annual Young
Clinician of the Year Award during the Arab Health
Achievement & Innovation Awards.
This year’s winner of the Cleveland Clinic’s
Young Clinician of the Year Award is Dr Dima
Abdelmannan, a consultant endocrinologist at
Dubai Diabetes Center, Dubai Health Authority,
and Associate Clinical Dean at Dubai Medical
College. Dr Abdelmannan holds dual board
degrees in internal medicine and endocrinology
from both the US and UK.
The Young Clinician of the Year Award is given
to a physician under the age of 40 who has made a
positive impact on patients’ lives in the Middle East.
Physicians are nominated by an institution or their
peers. A judging panel, chaired by William Carey,
MD, and Director of the Center for Continuing
Education at Cleveland Clinic, Ohio, USA, reviewed
the nominations. The selection criteria includes
evident medical acumen and leadership; dedication
to excellence and quality care; demonstration of
empathy and compassion in all aspects of care;
commitment to continuing medical education, and
engagement in research.
“For the fourth year, Cleveland Clinic is
honouring a young physician who displays not
only leadership and commitment, but also
compassion for patients”, said Dr Carey. “As a part
of the Arab Health Awards, we will continue to
honour healthcare’s future leaders in the Middle
East annually. This year there were 11 high quality
applications for this award from five countries
including Saudi Arabia, Kuwait, Qatar, UAE, and
Egypt.The task of the committee to select one best
from such a talent pool was never more difficult. It
is gratifying to see so many young people achieving
professional excellence.”
As this year’s winner, Dr Dima Abdelmannen
will receive the opportunity to observe clinical
operations at Cleveland Clinic’s main campus in
the US for one week, hosted and sponsored by
the Cleveland Clinic’s Center for International
Medical Education in collaboration with Informa,
the organiser of Arab Health.
“Our goal is to reward excellence and to add
value to healthcare reform that the Middle East
region is witnessing. Our presence in the Arab
Health Congress helps achieve that”, said Robert
Stall, Executive Director of International Operations
at Cleveland Clinic. “Cleveland Clinic is committed
to the growth and development of healthcare’s
future leaders worldwide and is consistently willing
to engage in such initiatives in the region.”
According to the judging panel of the award,
“Dr Dima Abdelmannan has a solid record at a
young age. We not only received feedback from her
peers and her organisation, but also from one of
her patients. She stands out in a very competitive
group of applicants for this award. Dr Abdelmannan
has been educated in Dubai, Cleveland, and Boston.
Evidence of acumen and leadership abounds as
she has served for four years as Assistant Chief
of Endocrinology at a major US medical school,
and for the past year served as Vice Dean of the
Dubai Medical College. She has demonstrated
extraordinary success in improving quality of care
through evidence-based research and incorporated
rapid changes in the structure and delivery of
services. She works closely with patients in helping
them make informed decisions in their treatment
which all falls under patient-centred care. As a
one of few female endocrinologists, she helped
many women suffering from gestational diabetes
during their pregnancy journey with compassion.
She developed different educational programmes
for patients. Commitment to medical education
has been a constant theme throughout her career.
She has widely published in peer reviewed medical
journals. She has played a vital role in raising the
awareness of the community, and promoting health
in UAE. Her energy, initiative and dedication to
improving the quality of care make her an ideal
recipient of the Cleveland Clinic Young Clinician
Award.”
The Arab Health Achievement and Innovation
Awards are held annually and recognise the
outstanding achievements of individuals, hospitals,
departments, and teams that have contributed
to the growth and development of the Arab
Health industry. Informa Life Sciences Exhibitions
developed the Arab Health Achievement &
Innovation Awards to reward industry leaders and
innovators in a variety of industry categories.
Dr Carey with the winner of the Cleveland Clinic Young Clinician of the Year Award, Dr Dima Abdelmannan
LONG-TERM USE OF HORMONAL CONTRACEPTIVES IS
ASSOCIATED WITH AN INCREASED RISK OF BRAIN TUMOURS
T
aking a hormonal contraceptive for
at least five years is associated with a
possible increase in a young woman’s
risk of developing a rare tumour, glioma of the
brain. This project focussed on women aged
15-49 years and the findings are published in
the British Journal of Clinical Pharmacology.
While only a little is known about the
causes of glioma and other brain tumours,
there is some evidence that female sex
hormones may increase the risk of some
cancer types, although there is also evidence
that contraceptive use may reduce the
risk in cer tain age groups. “This prompted
us to evaluate whether using hormonal
contraceptives might influence the risk of
gliomas in women of the age range who use
them”, says research team leader Dr David
Gaist of the Odense University Hospital
and University of Southern Denmark.
In
this project, the researchers drew data from
Denmark’s national administrative and health
registries, enabling them to identify all the
women in Denmark who were between
15 and 49 years of age and had a firsttime diagnosis of glioma between 2000 and
2009. They found 317 cases and compared
each of these women with eight agematched women who didn’t have gliomas.
“It is impor tant to keep this apparent
increase in risk in context,” says Dr Gaist. “In
a population of women in the reproductive
age, including those who use hormonal
contraceptives, you would anticipate seeing 5
in 100,000 people develop a glioma annually,
according to the nationwide Danish Cancer
Registr y. “While we found a statistically
significant association between hormonal
contraceptive use and glioma risk, a riskbenefit evaluation would still favour the
use of hormonal contraceptives in eligible
users”, says Dr Gaist, who points out that it
is impor tant to carr y on evaluating long-term
contraceptive use in order to help women
choose the best contraception for them.
Dr Gaist also emphasises that the findings
need to be interpreted with care, as discussed
in the published research paper. “Despite that,
we feel our study is an impor tant contribution
and we hope that our findings will spark fur ther
research on the relationship between female
hormonal agents and glioma risk”, he says.
#arabhealth
@arab_health
11
ARAB HEALTH daily dose
SELFIE
COMPETITION
12
facebook.com/arabhealth
WIN
a Samsung
Tweet your selfie to @arab_health
along with #arabhealth
Galaxy Tab3
Upload your images at
arabhealthonline.com/competition
THURSDAY 29 January 2015
The ICG System from KARL STORZ
All the important information at a glance –
for additional safety
0
t
5
a
F
s
u
h
t
t
i
o
t
i
o
s
Vi l 4 B
l
a
H
Bile ducts displayed in
the white light mode
Bile ducts displayed in the
ICG standard mode
FI 10-1 01/2014/A-LB
Bile ducts displayed in the
ICG/SPECTRA A mode
KARL STORZ GmbH & Co. KG, Mittelstraße 8, 78532 Tuttlingen/Germany Phone: +49 (0)7461 708-0, Fax: + 49 (0)7461 708-105, E-Mail: [email protected]
KARL STORZ Endoskope – East Mediterranean and Gulf S.A.L, Block M, 3rd Floor, Beirut Souks, Weygand Street, 2012 3301 Beirut/Lebanon,
Phone: +961 (1) 999390, Fax: +961 (1) 999391, E-mail: [email protected]
www.karlstorz.com
#arabhealth
@arab_health
13
ARAB HEALTH daily dose
ENDOALPHA INTEGRATED OPERATING THEATRES
Improve productivity & patient outcomes through standardisation & theatre integration.
ENDOALPHA provides a range of products and services to deliver state-of-the-art Endoscopy Suites and Operating Theatres.
Visit us on stand 3E30 at Arab Health 2015.
Follow us on Twitter @OlympusMedUIMEA
www.olympus.co.uk/medical
14
facebook.com/arabhealth
THURSDAY 29 January 2015
“Everything we do,
we do with passion –
and we do it
for life.”
Stefan Dräger, Chairman of the Executive Board
015
30
ealt h 2
Arab H ll 3, Booth S3D
e
h
t
t
a
a
s
H
u
d
it
e
Vis
K. Sae
: SH
5416
Located
www.draeger.com/arabhealth
#arabhealth
@arab_health
15
ARAB HEALTH daily dose
Track Haemoglobin
Changes in Real Time
with Noninvasive and Continuous Haemoglobin (SpHb ) Monitoring
®
Please
visit Masimo
Saeed Hall,
Stand S1H50
Enhance patient care with real-time visibility to whether
haemoglobin is stable, dropping, or rising.
5%
4.5%
4%
SpHb Impact in Higher Blood Loss Surgery2
87%
2.5
Average RBC Units Transfused Per Patient
Frequency of Intraoperative Blood Transfusions
SpHb Impact in Lower Blood Loss Surgery1
Reduction in Blood
Transfusion Frequency
3%
2%
1%
0.6%*
0%
1.9
2
0.9
Average RBC Units
Reduced Per Patient
1.5
1.0**
1
0.5
0
Standard Care Group
SpHb Group
Randomized controlled trial in 327 orthopedic patients.
*p=0.03 vs Standard Care Group
Standard Care Group
SpHb Group
Prospective cohort study in 106 neurosurgery patients.
**p<0.001 vs Standard Care Group
When used in conjunction with laboratory testing, SpHb monitoring has been shown
to help clinicians reduce blood transfusion in both lower and higher blood loss surgery,
and to help clinicians initiate more timely transfusions when they are truly indicated.
To learn more, visit www.masimo.co.uk/haemoglobin
1
Ehrenfeld JM, et al. American Society of Anesthesiologists. 2010;LB05. 2 Awada WFN et
al. Proceeding of the Society for Technology in Anesthesia Annual Meeting, 2013: p 51.
Caution: Federal law restricts this device to sale by or on the order of a physician.
16
facebook.com/arabhealth
+41 32 720 1188 | www.masimo.co.uk
© 2014 Masimo. All rights reserved.